First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.

@article{Colodner2007FirstNS,
  title={First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.},
  author={Raul Colodner and Zmira Samra and Nathan Keller and Hanna Sprecher and Colin Block and Nehama Peled and Tzilia Lazarovitch and Rita Bardenstein and Orna Schwartz-Harari and Yehuda Carmeli},
  journal={Diagnostic microbiology and infectious disease},
  year={2007},
  volume={57 2},
  pages={201-5}
}
In this 1st national surveillance study, the susceptibility pattern of 1011 consecutive isolates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. isolated from patients hospitalized in Israel hospitals, covering 62.3% of all general hospital beds in the country, was investigated. Proportion of susceptibilities (range among institutions, MIC(50)/MIC(90) in micrograms per milliliter) were to ertapenem 95.0% (88.8-100%, 0.19/0.75), imipenem 98.8% (88.8-100… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases • 2012
View 1 Excerpt

In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli

European Journal of Clinical Microbiology & Infectious Diseases • 2011
View 2 Excerpts

Similar Papers

Loading similar papers…